These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15920768)

  • 1. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Jolivette LJ; Ward KW
    J Pharm Sci; 2005 Jul; 94(7):1467-83. PubMed ID: 15920768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
    Evans CA; Jolivette LJ; Nagilla R; Ward KW
    Drug Metab Dispos; 2006 Jul; 34(7):1255-65. PubMed ID: 16621936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):612-9. PubMed ID: 15155552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of molecular properties to extrapolation of the volume of distribution in human from preclinical animal species data.
    Sui X; Sun J; Li H; Pan Y; Wang Y; He Z
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):464-75. PubMed ID: 20878878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
    Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
    Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance.
    Lombardo F; Waters NJ; Argikar UA; Dennehy MK; Zhan J; Gunduz M; Harriman SP; Berellini G; Liric Rajlic I; Obach RS
    J Clin Pharmacol; 2013 Feb; 53(2):178-91. PubMed ID: 23436263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies prediction of human drug clearance based on scaling data from one or two animal species.
    Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E
    Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.
    Hildebrand M
    Prostaglandins; 1994 Nov; 48(5):297-312. PubMed ID: 7531864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: oral clearance.
    Wajima T; Fukumura K; Yano Y; Oguma T
    J Pharm Sci; 2003 Dec; 92(12):2427-40. PubMed ID: 14603488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
    Ward KW; Nagilla R; Jolivette LJ
    Xenobiotica; 2005 Feb; 35(2):191-210. PubMed ID: 16019946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state.
    Lombardo F; Waters NJ; Argikar UA; Dennehy MK; Zhan J; Gunduz M; Harriman SP; Berellini G; Rajlic IL; Obach RS
    J Clin Pharmacol; 2013 Feb; 53(2):167-77. PubMed ID: 23436262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of neural networks for the prediction of human pharmacokinetic parameters.
    Ritschel WA; Akileswaran R; Hussain AS
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):629-43. PubMed ID: 8786678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
    Poulin P; Jones HM; Jones RD; Yates JW; Gibson CR; Chien JY; Ring BJ; Adkison KK; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Ku MS
    J Pharm Sci; 2011 Oct; 100(10):4050-73. PubMed ID: 21523782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis.
    Wajima T; Fukumura K; Yano Y; Oguma T
    J Pharm Sci; 2002 Dec; 91(12):2489-99. PubMed ID: 12434392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.